| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Addition of CpG ODN to recombinant Pseudomonas aeruginosa ExoProtein A conjugates of AMA1 and Pfs25 greatly increases the number of responders
|
Qian, Feng
|
|
2008
|
26 |
Supplement 1 |
p. 2521-2527
7 p.
|
artikel
|
| 2 |
Adjuvant effect of water-soluble polysaccharide (PAP) from the mycelium of Polyporus albicans on the immune responses to ovalbumin in mice
|
Sun, Yongxu
|
|
2008
|
26 |
Supplement 1 |
p. 3932-3936
5 p.
|
artikel
|
| 3 |
A double-blind, placebo-controlled study of the safety and immunogenicity of live, oral type 4 and type 7 adenovirus vaccines in adults
|
Lyons, Arthur
|
|
2008
|
26 |
Supplement 1 |
p. 2890-2898
9 p.
|
artikel
|
| 4 |
A heterologous DNA prime/protein boost immunization strategy for rhesus cytomegalovirus
|
Abel, Kristina
|
|
2008
|
26 |
Supplement 1 |
p. 6013-6025
13 p.
|
artikel
|
| 5 |
“All that palsies is not Bell's [1]”—The need to define Bell's palsy as an adverse event following immunization
|
Rath, Barbara
|
|
2007
|
26 |
Supplement 1 |
p. 1-14
14 p.
|
artikel
|
| 6 |
A local reaction at or near injection site: Case definition and guidelines for collection, analysis, and presentation of immunization safety data
|
Gidudu, Jane
|
|
2008
|
26 |
Supplement 1 |
p. 6800-6813
14 p.
|
artikel
|
| 7 |
Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines
|
Verstraeten, Thomas
|
|
2008
|
26 |
Supplement 1 |
p. 6630-6638
9 p.
|
artikel
|
| 8 |
A nasal vaccine comprising B-subunit derivative of Shiga toxin 2 for cross-protection against Shiga toxin types 1 and 2
|
Tsuji, Takao
|
|
2008
|
26 |
Supplement 1 |
p. 2092-2099
8 p.
|
artikel
|
| 9 |
An HSV-1 gD mutant virus as an entry-impaired live virus vaccine
|
Awasthi, Sita
|
|
2008
|
26 |
Supplement 1 |
p. 1195-1203
9 p.
|
artikel
|
| 10 |
An immunisation strategy for the protection of cattle against alcelaphine herpesvirus-1-induced malignant catarrhal fever
|
Haig, David M.
|
|
2008
|
26 |
Supplement 1 |
p. 4461-4468
8 p.
|
artikel
|
| 11 |
Antibody response after vaccination with tetanus and diphtheria toxoids in human T-cell lymphotropic virus type 1 asymptomatic carriers
|
Biasutti, Claudia
|
|
2008
|
26 |
Supplement 1 |
p. 2808-2810
3 p.
|
artikel
|
| 12 |
A Phase 1 trial of PfCP2.9: An AMA1/MSP1 chimeric recombinant protein vaccine for Plasmodium falciparum malaria
|
Malkin, Elissa
|
|
2008
|
26 |
Supplement 1 |
p. 6864-6873
10 p.
|
artikel
|
| 13 |
Application of quantitative gene expression analysis for pertussis vaccine safety control
|
Hamaguchi, Isao
|
|
2008
|
26 |
Supplement 1 |
p. 4686-4696
11 p.
|
artikel
|
| 14 |
A promising balanced Th1 and Th2 directing immunological adjuvant, saponins from the root of Platycodon grandiflorum
|
Xie, Yong
|
|
2008
|
26 |
Supplement 1 |
p. 3937-3945
9 p.
|
artikel
|
| 15 |
A 5-year follow-up of antibody response in children vaccinated with single dose of live attenuated SA14-14-2 Japanese encephalitis vaccine: Immunogenicity and anamnestic responses
|
Sohn, Young Mo
|
|
2008
|
26 |
Supplement 1 |
p. 1638-1643
6 p.
|
artikel
|
| 16 |
B cell immunopathology during HIV-1 infection: Lessons to learn for HIV-1 vaccine design
|
Cagigi, Alberto
|
|
2008
|
26 |
Supplement 1 |
p. 3016-3025
10 p.
|
artikel
|
| 17 |
BCG osteomyelitis caused by the BCG Tokyo strain and confirmed by molecular method
|
Kim, So Hee
|
|
2008
|
26 |
Supplement 1 |
p. 4379-4381
3 p.
|
artikel
|
| 18 |
Binding of complement regulatory proteins to Group A Streptococcus
|
Oliver, Maria A.
|
|
2008
|
26 |
Supplement 1 |
p. I75-I78
nvt p.
|
artikel
|
| 19 |
Bioneedles™ as vaccine carriers
|
Hirschberg, Hoang J.H.B.
|
|
2008
|
26 |
Supplement 1 |
p. 2389-2397
9 p.
|
artikel
|
| 20 |
Boosting BCG vaccination with MVA85A down-regulates the immunoregulatory cytokine TGF-β1
|
Fletcher, Helen A.
|
|
2008
|
26 |
Supplement 1 |
p. 5269-5275
7 p.
|
artikel
|
| 21 |
CD40L expressed from the canarypox vector, ALVAC, can boost immunogenicity of HIV-1 canarypox vaccine in mice and enhance the in vitro expansion of viral specific CD8+ T cell memory responses from HIV-1-infected and HIV-1-uninfected individuals
|
Liu, Jun
|
|
2008
|
26 |
Supplement 1 |
p. 4062-4072
11 p.
|
artikel
|
| 22 |
Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects
|
Guy, Bruno
|
|
2008
|
26 |
Supplement 1 |
p. 5712-5721
10 p.
|
artikel
|
| 23 |
Cellular and humoral responses to tetanus vaccination in gabonese children
|
van Riet, E.
|
|
2008
|
26 |
Supplement 1 |
p. 3690-3695
6 p.
|
artikel
|
| 24 |
Characterization of immune responses elicited in mice by intranasal co-immunization with HIV-1 Tat, gp140 ΔV2Env and/or SIV Gag proteins and the nontoxicogenic heat-labile Escherichia coli enterotoxin
|
Caputo, Antonella
|
|
2008
|
26 |
Supplement 1 |
p. 1214-1227
14 p.
|
artikel
|
| 25 |
Chemokine receptor-mediated delivery of mycobacterial MPT51 protein efficiently induces antigen-specific T-cell responses
|
Uchijima, Masato
|
|
2008
|
26 |
Supplement 1 |
p. 5165-5169
5 p.
|
artikel
|
| 26 |
Chimeric hepatitis B virus core particles carrying an epitope of anthrax protective antigen induce protective immunity against Bacillus anthracis
|
Yin, Ying
|
|
2008
|
26 |
Supplement 1 |
p. 5814-5821
8 p.
|
artikel
|
| 27 |
Chimeric vapA/groEL2 DNA vaccines enhance clearance of Rhodococcus equi in aerosol challenged C3H/He mice
|
Phumoonna, Tongted
|
|
2008
|
26 |
Supplement 1 |
p. 2457-2465
9 p.
|
artikel
|
| 28 |
Cloning, expression and evaluation of the efficacy of a recombinant Eimeria tenella sporozoite antigen in birds
|
Mohana Subramanian, B.
|
|
2008
|
26 |
Supplement 1 |
p. 3489-3496
8 p.
|
artikel
|
| 29 |
Codelivery of PEG-IFN-α inhibits HCV DNA vaccine-induced T cell responses but not humoral responses in African green monkeys
|
Park, Su-Hyung
|
|
2008
|
26 |
Supplement 1 |
p. 3978-3983
6 p.
|
artikel
|
| 30 |
Combination of treatment with death receptor 5-specific antibody with therapeutic HPV DNA vaccination generates enhanced therapeutic anti-tumor effects
|
Tseng, Chih Wen
|
|
2008
|
26 |
Supplement 1 |
p. 4314-4319
6 p.
|
artikel
|
| 31 |
Combining a hybrid genetic algorithm and a heat transfer model to optimise an insulated box for use in the transport of perishables
|
East, A.R.
|
|
2008
|
26 |
Supplement 1 |
p. 1322-1334
13 p.
|
artikel
|
| 32 |
Community heroes or “high-risk” pariahs? Reasons for declining to enroll in an HIV vaccine trial
|
Newman, Peter A.
|
|
2008
|
26 |
Supplement 1 |
p. 1091-1097
7 p.
|
artikel
|
| 33 |
Comparative ability of various plasmid-based cytokines and chemokines to adjuvant the activity of HIV plasmid DNA vaccines
|
Xu, Rong
|
|
2008
|
26 |
Supplement 1 |
p. 4819-4829
11 p.
|
artikel
|
| 34 |
Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants
|
Gatchalian, Salvacion
|
|
2008
|
26 |
Supplement 1 |
p. 2234-2241
8 p.
|
artikel
|
| 35 |
Comparison of α-Type-1 polarizing and standard dendritic cell cytokine cocktail for maturation of therapeutic monocyte-derived dendritic cell preparations from cancer patients
|
Trepiakas, Redas
|
|
2008
|
26 |
Supplement 1 |
p. 2824-2832
9 p.
|
artikel
|
| 36 |
Complement and antibodies: A dangerous liaison in HIV infection?
|
Stoiber, Heribert
|
|
2008
|
26 |
Supplement 1 |
p. I79-I85
nvt p.
|
artikel
|
| 37 |
Complicated otitis media and its implications
|
Leibovitz, Eugene
|
|
2008
|
26 |
Supplement 1 |
p. G16-G19
nvt p.
|
artikel
|
| 38 |
Corrigendum to “Influenza vaccine effectiveness among 50–64-year-old persons during a season of poor antigenic match between vaccine and circulating influenza virus strains: Colorado, United States, 2003–2004” [Vaccine 25 (1) (2006) 154–160]
|
Herrera, Guillermo A.
|
|
2008
|
26 |
Supplement 1 |
p. 4101-4103
3 p.
|
artikel
|
| 39 |
Cost-effectiveness of adult pertussis vaccination in Germany
|
Lee, Grace M.
|
|
2008
|
26 |
Supplement 1 |
p. 3673-3679
7 p.
|
artikel
|
| 40 |
CpG motif-based adjuvant as a replacement for Freund's complete adjuvant in a recombinant LHRH vaccine
|
Conforti, Valéria A.
|
|
2008
|
26 |
Supplement 1 |
p. 907-913
7 p.
|
artikel
|
| 41 |
Cross-clade immune responses to Gag p24 in patients infected with different HIV-1 subtypes and correlation with HLA class I and II alleles
|
Gudmundsdotter, L.
|
|
2008
|
26 |
Supplement 1 |
p. 5182-5187
6 p.
|
artikel
|
| 42 |
Cross-clade protective immunity of H5N1 influenza vaccines in a mouse model
|
Murakami, Shin
|
|
2008
|
26 |
Supplement 1 |
p. 6398-6404
7 p.
|
artikel
|
| 43 |
Cross-genotype-reactivity of the immunodominant HCV CD8 T-cell epitope NS3-1073
|
Fytili, P.
|
|
2008
|
26 |
Supplement 1 |
p. 3818-3826
9 p.
|
artikel
|
| 44 |
Cross-protection by MF59™-adjuvanted influenza vaccine: Neutralizing and haemagglutination-inhibiting antibody activity against A(H3N2) drifted influenza viruses
|
Ansaldi, Filippo
|
|
2008
|
26 |
Supplement 1 |
p. 1525-1529
5 p.
|
artikel
|
| 45 |
Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime–protein boost HIV-1 vaccine in healthy human volunteers
|
Wang, Shixia
|
|
2008
|
26 |
Supplement 1 |
p. 1098-1110
13 p.
|
artikel
|
| 46 |
Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime–protein boost HIV-1 vaccine in healthy human volunteers
|
Wang, Shixia
|
|
2008
|
26 |
Supplement 1 |
p. 3947-3957
11 p.
|
artikel
|
| 47 |
Deceptive imprinting and immune refocusing in vaccine design
|
Tobin, Gregory J.
|
|
2008
|
26 |
Supplement 1 |
p. 6189-6199
11 p.
|
artikel
|
| 48 |
Delayed early antiretroviral treatment is associated with an HIV-specific long-term cellular response in HIV-1 vertically infected infants
|
Palma, Paolo
|
|
2008
|
26 |
Supplement 1 |
p. 5196-5201
6 p.
|
artikel
|
| 49 |
Delivery of DNA HIV-1 vaccine to the liver induces high and long-lasting humoral immune responses
|
Raska, Milan
|
|
2008
|
26 |
Supplement 1 |
p. 1541-1551
11 p.
|
artikel
|
| 50 |
Differential immunogenicity of vaccinia and HIV-1 components of a human recombinant vaccine in mucosal and blood compartments
|
Anton, Peter A.
|
|
2008
|
26 |
Supplement 1 |
p. 4617-4623
7 p.
|
artikel
|
| 51 |
Direct effect of Plasmodium vivax recombinant vaccine candidates AMA-1 and MSP-119 on the innate immune response
|
Bueno, Lilian Lacerda
|
|
2008
|
26 |
Supplement 1 |
p. 1204-1213
10 p.
|
artikel
|
| 52 |
DNA fusion vaccines incorporating IL-23 or RANTES for use in immunization against influenza
|
Williman, J.
|
|
2008
|
26 |
Supplement 1 |
p. 5153-5158
6 p.
|
artikel
|
| 53 |
Double immunization strategy with a BoHV-4-vectorialized secreted chimeric peptide BVDV-E2/BoHV-1-gD
|
Donofrio, G.
|
|
2008
|
26 |
Supplement 1 |
p. 6031-6042
12 p.
|
artikel
|
| 54 |
Double-stranded RNA- and CpG DNA-induced immune responses in Atlantic salmon: Comparison and synergies
|
Strandskog, Guro
|
|
2008
|
26 |
Supplement 1 |
p. 4704-4715
12 p.
|
artikel
|
| 55 |
Dynamics and control of measles in Portugal: Accessing the impact of anticipating the age for the first dose of MMR from 15 to 12 months of age
|
Paulo, Ana Cristina
|
|
2008
|
26 |
Supplement 1 |
p. 2418-2427
10 p.
|
artikel
|
| 56 |
Dynamics of acute and memory mucosal and systemic immune responses against HIV-1 envelope following immunizations through single or combinations of mucosal and systemic routes
|
Srivastava, Indresh
|
|
2008
|
26 |
Supplement 1 |
p. 2796-2806
11 p.
|
artikel
|
| 57 |
Early Experience with Human Papillomavirus Vaccine Introduction in the United States, Canada and Australia
|
Shefer, Abigail
|
|
2008
|
26 |
Supplement 1 |
p. K68-K75
nvt p.
|
artikel
|
| 58 |
Economic evaluation of varicella vaccination in Italian children and adolescents according to different intervention strategies: The burden of uncomplicated hospitalised cases
|
Bonanni, Paolo
|
|
2008
|
26 |
Supplement 1 |
p. 5619-5626
8 p.
|
artikel
|
| 59 |
Economics of polio vaccination in the post-eradication era: Should OPV-using countries adopt IPV?
|
Khan, M. Mahmud
|
|
2008
|
26 |
Supplement 1 |
p. 2034-2040
7 p.
|
artikel
|
| 60 |
Editorial Board
|
|
|
2008
|
26 |
Supplement 1 |
p. CO2-
1 p.
|
artikel
|
| 61 |
Editorial Board
|
|
|
2008
|
26 |
Supplement 1 |
p. CO2-
1 p.
|
artikel
|
| 62 |
Editorial Board
|
|
|
2008
|
26 |
Supplement 1 |
p. CO2-
1 p.
|
artikel
|
| 63 |
Editorial Board
|
|
|
2008
|
26 |
Supplement 1 |
p. CO2-
1 p.
|
artikel
|
| 64 |
Editorial Board
|
|
|
2008
|
26 |
Supplement 1 |
p. CO2-
1 p.
|
artikel
|
| 65 |
Editorial Board/Aims and Scope
|
|
|
2008
|
26 |
Supplement 1 |
p. CO2-
1 p.
|
artikel
|
| 66 |
Editorial Board/Aims and Scope
|
|
|
2008
|
26 |
Supplement 1 |
p. CO2-
1 p.
|
artikel
|
| 67 |
Editorial Board/Aims and Scope
|
|
|
2008
|
26 |
Supplement 1 |
p. CO2-
1 p.
|
artikel
|
| 68 |
Effectiveness of a physician peer educator in improving the quality of immunization services for young children in primary care practices
|
Taylor, James A.
|
|
2008
|
26 |
Supplement 1 |
p. 4256-4261
6 p.
|
artikel
|
| 69 |
Effectiveness of hexavalent vaccines against invasive Haemophilus influenzae type b disease: Germany's experience after 5 years of licensure
|
Kalies, Helen
|
|
2008
|
26 |
Supplement 1 |
p. 2545-2552
8 p.
|
artikel
|
| 70 |
Efficacy and safety of cell associated vaccines against Marek's disease virus grown in a continuous cell line from chickens
|
Geerligs, Harm
|
|
2008
|
26 |
Supplement 1 |
p. 5595-5600
6 p.
|
artikel
|
| 71 |
Efficient augmentation of a long-lasting immune responses in HIV-1 gag DNA vaccination by IL-15 plasmid boosting
|
Li, Wenjing
|
|
2008
|
26 |
Supplement 1 |
p. 3282-3290
9 p.
|
artikel
|
| 72 |
Efficient generation of survivin-specific cytotoxic T lymphocytes from healthy persons in vitro: Quantitative and qualitative effects of CD4+ T cells
|
Kim, Eun-Kyung
|
|
2008
|
26 |
Supplement 1 |
p. 3987-3997
11 p.
|
artikel
|
| 73 |
Efficient induction of oral tolerance by fusing cholera toxin B subunit with allergen-specific T-cell epitopes accumulated in rice seed
|
Takagi, Hidenori
|
|
2008
|
26 |
Supplement 1 |
p. 6027-6030
4 p.
|
artikel
|
| 74 |
Enhanced in vivo transgene expression and immunogenicity from plasmid vectors following electrostimulation in rodents and primates
|
Simon, Adam J.
|
|
2008
|
26 |
Supplement 1 |
p. 5202-5209
8 p.
|
artikel
|
| 75 |
Enhancement of epitope-specific cellular immune responses by immunization with HIV-1 peptides genetically conjugated to the B-subunit of recombinant cholera toxin
|
Boberg, A.
|
|
2008
|
26 |
Supplement 1 |
p. 5079-5082
4 p.
|
artikel
|
| 76 |
Enhancement of HIV DNA vaccine immunogenicity by the NKT cell ligand, α-galactosylceramide
|
Huang, Yaoxing
|
|
2008
|
26 |
Supplement 1 |
p. 1807-1816
10 p.
|
artikel
|
| 77 |
Epidemiology and Natural History of Human Papillomavirus Infections and Type-Specific Implications in Cervical Neoplasia
|
Bosch, F. Xavier
|
|
2008
|
26 |
Supplement 1 |
p. K1-K16
nvt p.
|
artikel
|
| 78 |
Erratum to “Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime–protein boost HIV-1 vaccine in healthy human volunteers” [Vaccine 26 (2008) 1098–1110]
|
|
|
2008
|
26 |
Supplement 1 |
p. 3946-
1 p.
|
artikel
|
| 79 |
European Sero-Epidemiology Network 2: Standardisation of immunoassay results for pertussis requires homogeneity in the antigenic preparations
|
Giammanco, Anna
|
|
2008
|
26 |
Supplement 1 |
p. 4486-4493
8 p.
|
artikel
|
| 80 |
Evaluation of a vectored equine herpesvirus type 1 (EHV-1) vaccine expressing H3 haemagglutinin in the protection of dogs against canine influenza
|
Rosas, Cristina
|
|
2008
|
26 |
Supplement 1 |
p. 2335-2343
9 p.
|
artikel
|
| 81 |
Evaluation of recombinant Onchocerca volvulus activation associated protein-1 (ASP-1) as a potent Th1-biased adjuvant with a panel of protein or peptide-based antigens and commercial inactivated vaccines
|
Xiao, Wenjun
|
|
2008
|
26 |
Supplement 1 |
p. 5022-5029
8 p.
|
artikel
|
| 82 |
Evaluation of systemic and mucosal anti-HPV16 and anti-HPV18 antibody responses from vaccinated women
|
Kemp, Troy J.
|
|
2008
|
26 |
Supplement 1 |
p. 3608-3616
9 p.
|
artikel
|
| 83 |
Evaluation of the Friend Virus model for the development of improved adenovirus-vectored anti-retroviral vaccination strategies
|
Bayer, Wibke
|
|
2008
|
26 |
Supplement 1 |
p. 716-726
11 p.
|
artikel
|
| 84 |
Evaluation of the potential of synthetic peptides of 80kDa human sperm antigen (80kDaHSA) for the development of contraceptive vaccine for male
|
Khobarekar, Bharati Gangaram
|
|
2008
|
26 |
Supplement 1 |
p. 3711-3718
8 p.
|
artikel
|
| 85 |
Evaluation of widely consumed botanicals as immunological adjuvants
|
Ragupathi, Govind
|
|
2008
|
26 |
Supplement 1 |
p. 4860-4865
6 p.
|
artikel
|
| 86 |
EV02: A Phase I trial to compare the safety and immunogenicity of HIV DNA-C prime-NYVAC-C boost to NYVAC-C alone
|
McCormack, Sheena
|
|
2008
|
26 |
Supplement 1 |
p. 3162-3174
13 p.
|
artikel
|
| 87 |
Exercise enhances vaccine-induced antigen-specific T cell responses
|
Rogers, Connie J.
|
|
2008
|
26 |
Supplement 1 |
p. 5407-5415
9 p.
|
artikel
|
| 88 |
First administration to humans of a monoclonal antibody cocktail against rabies virus: Safety, tolerability, and neutralizing activity
|
Bakker, A.B.H.
|
|
2008
|
26 |
Supplement 1 |
p. 5922-5927
6 p.
|
artikel
|
| 89 |
Functional T-cell responses generated by dendritic cells expressing the early HIV-1 proteins Tat, Rev and Nef
|
Allard, Sabine D.
|
|
2008
|
26 |
Supplement 1 |
p. 3735-3741
7 p.
|
artikel
|
| 90 |
Gene profiling analysis of ALVAC infected human monocyte derived dendritic cells
|
Harenberg, Anke
|
|
2008
|
26 |
Supplement 1 |
p. 5004-5013
10 p.
|
artikel
|
| 91 |
Generic construction of single component particles that elicit humoural and cellular immune responses without the need for adjuvants
|
White, P.J.
|
|
2008
|
26 |
Supplement 1 |
p. 6824-6831
8 p.
|
artikel
|
| 92 |
Genetic characterisation of attenuated SAD rabies virus strains used for oral vaccination of wildlife
|
Geue, Lutz
|
|
2008
|
26 |
Supplement 1 |
p. 3227-3235
9 p.
|
artikel
|
| 93 |
Gene transfer of AIMP1 and B7.1 into epitope-loaded, fibroblasts induces tumor-specific CTL immunity, and prolongs the survival period of tumor-bearing mice
|
Kim, Tae S.
|
|
2008
|
26 |
Supplement 1 |
p. 5928-5934
7 p.
|
artikel
|
| 94 |
“Guidelines for the clinical evaluation of dengue vaccines in endemic areas”: Summary of a World Health Organization Technical Consultation
|
Edelman, Robert
|
|
2008
|
26 |
Supplement 1 |
p. 4113-4119
7 p.
|
artikel
|
| 95 |
High titer growth of human and avian influenza viruses in an immortalized chick embryo cell line without the need for exogenous proteases
|
Smith, Kristen A.
|
|
2008
|
26 |
Supplement 1 |
p. 3778-3782
5 p.
|
artikel
|
| 96 |
HIV-1 envelope glycoprotein-mediated fusion and pathogenesis: Implications for therapy and vaccine development
|
Jacobs, Amy
|
|
2008
|
26 |
Supplement 1 |
p. 3026-3035
10 p.
|
artikel
|
| 97 |
HIV-1 reverse transcriptase artificially targeted for proteasomal degradation induces a mixed Th1/Th2-type immune response
|
Starodubova, Elizaveta S.
|
|
2008
|
26 |
Supplement 1 |
p. 5170-5176
7 p.
|
artikel
|
| 98 |
H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses
|
Mahmood, Kutubuddin
|
|
2008
|
26 |
Supplement 1 |
p. 5393-5399
7 p.
|
artikel
|
| 99 |
Host genetic factors that control immune responses to retrovirus infections
|
Miyazawa, Masaaki
|
|
2008
|
26 |
Supplement 1 |
p. 2981-2996
16 p.
|
artikel
|
| 100 |
HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine
|
Joura, Elmar A.
|
|
2008
|
26 |
Supplement 1 |
p. 6844-6851
8 p.
|
artikel
|
| 101 |
Identification of immunogenic HLA-B7 “Achilles’ heel” epitopes within highly conserved regions of HIV
|
De Groot, Anne S.
|
|
2008
|
26 |
Supplement 1 |
p. 3059-3071
13 p.
|
artikel
|
| 102 |
Identifying B and T cell epitopes and studying humoral, mucosal and cellular immune responses of peptides derived from V antigen of Yersinia pestis
|
Khan, Arif Azam
|
|
2008
|
26 |
Supplement 1 |
p. 316-332
17 p.
|
artikel
|
| 103 |
IL-15 as memory T-cell adjuvant for topical HIV-1 DermaVir vaccine
|
Calarota, Sandra A.
|
|
2008
|
26 |
Supplement 1 |
p. 5188-5195
8 p.
|
artikel
|
| 104 |
Immunization with an HIV-1 immunogen induces CD4+ and CD8+ HIV-1-specific polyfunctional responses in patients with chronic HIV-1 infection receiving antiretroviral therapy
|
Valor, L.
|
|
2008
|
26 |
Supplement 1 |
p. 2738-2745
8 p.
|
artikel
|
| 105 |
Immunogenetic basis of HIV-1 infection, transmission and disease progression
|
Singh, Paras
|
|
2008
|
26 |
Supplement 1 |
p. 2966-2980
15 p.
|
artikel
|
| 106 |
Immunogenicity and safety of aerosolized measles vaccine: Systematic review and meta-analysis
|
Low, Nicola
|
|
2008
|
26 |
Supplement 1 |
p. 383-398
16 p.
|
artikel
|
| 107 |
Immunogenicity and safety of a novel formalin-inactivated and alum-adjuvanted candidate subunit vaccine for mumps
|
Liang, Yan
|
|
2008
|
26 |
Supplement 1 |
p. 4276-4283
8 p.
|
artikel
|
| 108 |
Immunogenicity and safety of combined intradermal recombinant Hepatitis B with BCG vaccines at birth
|
Carniel, E.F.
|
|
2008
|
26 |
Supplement 1 |
p. 647-652
6 p.
|
artikel
|
| 109 |
Immunogenicity and safety of three consecutive lots of a new preservative-free inactivated hepatitis A vaccine (Healive®): A double-blind, randomized and controlled trial
|
Jiang, Wei-Ping
|
|
2008
|
26 |
Supplement 1 |
p. 2297-2301
5 p.
|
artikel
|
| 110 |
Immunogenicity and serotype-specific efficacy of a 9-valent pneumococcal conjugate vaccine (PCV-9) determined during an efficacy trial in The Gambia
|
Saaka, M.
|
|
2008
|
26 |
Supplement 1 |
p. 3719-3726
8 p.
|
artikel
|
| 111 |
Immunogenicity and tolerance following HIV-1/HBV plant-based oral vaccine administration
|
Guetard, Denise
|
|
2008
|
26 |
Supplement 1 |
p. 4477-4485
9 p.
|
artikel
|
| 112 |
Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles
|
Lalitha, P.V.
|
|
2008
|
26 |
Supplement 1 |
p. 4526-4535
10 p.
|
artikel
|
| 113 |
Immunogenicity, reactogenicity, and safety of a seven-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a fully liquid DTPa–IPV–HBV–Hib combination vaccine in healthy infants
|
Olivier, C.
|
|
2008
|
26 |
Supplement 1 |
p. 3142-3152
11 p.
|
artikel
|
| 114 |
Immunological adjuvant effect of Japanese ginseng saponins (JGS) on specific antibody and cellular response to ovalbumin and its haemolytic activities
|
Sun, Yongxu
|
|
2008
|
26 |
Supplement 1 |
p. 5911-5917
7 p.
|
artikel
|
| 115 |
Immunological profile of a Plasmodium vivax AMA-1 N-terminus peptide-carbon nanotube conjugate in an infected Plasmodium berghei mouse model
|
Yandar, Nubia
|
|
2008
|
26 |
Supplement 1 |
p. 5864-5873
10 p.
|
artikel
|
| 116 |
Immunopathological responses and kinetics of Brucella melitensis Rev 1 infection after subcutaneous or conjunctival vaccination in rams
|
Muñoz, Pilar-María
|
|
2008
|
26 |
Supplement 1 |
p. 2562-2569
8 p.
|
artikel
|
| 117 |
Impact of the introduction of pneumococcal conjugate vaccine on rates of community acquired pneumonia in children and adults
|
Nelson, Jennifer C.
|
|
2008
|
26 |
Supplement 1 |
p. 4947-4954
8 p.
|
artikel
|
| 118 |
Importance of the major Fli C antigenic site of Salmonella enteritidis as a subunit vaccine antigen
|
Toyota-Hanatani, Yukiko
|
|
2008
|
26 |
Supplement 1 |
p. 4135-4137
3 p.
|
artikel
|
| 119 |
Improved antibody responses in infants less than 1 year old using intradermal influenza vaccination
|
Sugimura, Tetsu
|
|
2008
|
26 |
Supplement 1 |
p. 2700-2705
6 p.
|
artikel
|
| 120 |
Improved HIV-1 specific T-cell responses by short-interval DNA tattooing as compared to intramuscular immunization in non-human primates
|
Verstrepen, Babs E.
|
|
2008
|
26 |
Supplement 1 |
p. 3346-3351
6 p.
|
artikel
|
| 121 |
Increasing the humoral immunogenic properties of the HIV-1 Tat protein using a ligand-stabilizing strategy
|
Lecoq, Alain
|
|
2008
|
26 |
Supplement 1 |
p. 2615-2626
12 p.
|
artikel
|
| 122 |
Induction of HIV-1 MPR649–684-specific IgA and IgG antibodies in caprine colostrum using a peptide-based vaccine
|
Dorosko, Stephanie M.
|
|
2008
|
26 |
Supplement 1 |
p. 5416-5422
7 p.
|
artikel
|
| 123 |
Induction of multispecific Th-1 type immune response against HCV in mice by protein immunization using CpG and Montanide ISA 720 as adjuvants
|
Qiu, Qi
|
|
2008
|
26 |
Supplement 1 |
p. 5527-5534
8 p.
|
artikel
|
| 124 |
Induction of opsonophagocytic killing activity with pneumococcal conjugate vaccine in human immunodeficiency virus-infected Ugandan adults
|
Chen, Meng
|
|
2008
|
26 |
Supplement 1 |
p. 4962-4968
7 p.
|
artikel
|
| 125 |
Infection of monocytes or immature dendritic cells (DCs) with an attenuated rabies virus results in DC maturation and a strong activation of the NFκB signaling pathway
|
Li, Jianwei
|
|
2008
|
26 |
Supplement 1 |
p. 419-426
8 p.
|
artikel
|
| 126 |
Influence of maternal antibody against hepatitis B surface antigen on active immune response to hepatitis B vaccine in infants
|
Hu, Yali
|
|
2008
|
26 |
Supplement 1 |
p. 6064-6067
4 p.
|
artikel
|
| 127 |
Inhaled delivery of 23-valent pneumococcal polysaccharide vaccine does not result in enhanced pulmonary mucosal immunoglobulin responses
|
Gordon, Stephen B.
|
|
2008
|
26 |
Supplement 1 |
p. 5400-5406
7 p.
|
artikel
|
| 128 |
Intestinal immunity following a combined enhanced inactivated polio vaccine/oral polio vaccine programme in Israel
|
Swartz, T.A.
|
|
2008
|
26 |
Supplement 1 |
p. 1083-1090
8 p.
|
artikel
|
| 129 |
Intranasal immunization of young mice with a multigene HIV-1 vaccine in combination with the N3 adjuvant induces mucosal and systemic immune responses
|
Bråve, Andreas
|
|
2008
|
26 |
Supplement 1 |
p. 5075-5078
4 p.
|
artikel
|
| 130 |
Introduction of Human Papillomavirus Vaccines into Developing Countries - International Strategies for Funding and Procurement
|
Andrus, Jon Kim
|
|
2008
|
26 |
Supplement 1 |
p. K87-K92
nvt p.
|
artikel
|
| 131 |
Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine
|
Fei-fei, Ge
|
|
2008
|
26 |
Supplement 1 |
p. 5590-5594
5 p.
|
artikel
|
| 132 |
Lessons from IAVI-006, a Phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers
|
Guimarães-Walker, A.
|
|
2008
|
26 |
Supplement 1 |
p. 6671-6677
7 p.
|
artikel
|
| 133 |
Lipid A and liposomes containing lipid A as antigens and adjuvants
|
Alving, Carl R.
|
|
2008
|
26 |
Supplement 1 |
p. 3036-3045
10 p.
|
artikel
|
| 134 |
Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990–2003
|
Asatryan, Armenak
|
|
2008
|
26 |
Supplement 1 |
p. 1166-1172
7 p.
|
artikel
|
| 135 |
Longitudinal analyses of immune responses to Plasmodium falciparum derived peptides corresponding to novel blood stage antigens in coastal Kenya
|
Agak, George W.
|
|
2008
|
26 |
Supplement 1 |
p. 1963-1971
9 p.
|
artikel
|
| 136 |
Long-term antibody persistence induced by a combined hepatitis A and B vaccine in children and adolescents
|
Diaz-Mitoma, Francisco
|
|
2008
|
26 |
Supplement 1 |
p. 1759-1763
5 p.
|
artikel
|
| 137 |
Long-term immunogenicity of a single dose of acellular pertussis vaccine in paediatric health-care workers
|
Littmann, Martina
|
|
2008
|
26 |
Supplement 1 |
p. 2344-2349
6 p.
|
artikel
|
| 138 |
Long-term increase of CD4+ central memory cells in HIV-1-infected individuals by therapeutic HIV-1 rgp160 immunization
|
Gudmundsdotter, Lindvi
|
|
2008
|
26 |
Supplement 1 |
p. 5107-5110
4 p.
|
artikel
|
| 139 |
Long-term stability of Vero cell-derived inactivated Japanese encephalitis vaccine prepared using serum-free medium
|
Toriniwa, Hiroko
|
|
2008
|
26 |
Supplement 1 |
p. 3680-3689
10 p.
|
artikel
|
| 140 |
Low dose revaccination induces robust protective anti-HBs antibody response in the majority of healthy non-responder neonates
|
Jafarzadeh, A.
|
|
2008
|
26 |
Supplement 1 |
p. 269-276
8 p.
|
artikel
|
| 141 |
Maternal immune status influences HIV-specific immune responses in pups after DNA prime protein boost using mucosal adjuvant
|
Bråve, Andreas
|
|
2008
|
26 |
Supplement 1 |
p. 5957-5966
10 p.
|
artikel
|
| 142 |
Microcarrier-based MDCK cell culture system for the production of influenza H5N1 vaccines
|
Hu, Alan Yung-Chih
|
|
2008
|
26 |
Supplement 1 |
p. 5736-5740
5 p.
|
artikel
|
| 143 |
Mixed allele malaria vaccines: Host protection and within-host selection
|
Barclay, Victoria C.
|
|
2008
|
26 |
Supplement 1 |
p. 6099-6107
9 p.
|
artikel
|
| 144 |
Modifying the HIV-1 env gp160 gene to improve pDNA vaccine-elicited cell-mediated immune responses
|
Megati, Shakuntala
|
|
2008
|
26 |
Supplement 1 |
p. 5083-5094
12 p.
|
artikel
|
| 145 |
Mumps vaccination coverage and vaccine effectiveness in a large outbreak among college students—Iowa, 2006
|
Marin, Mona
|
|
2008
|
26 |
Supplement 1 |
p. 3601-3607
7 p.
|
artikel
|
| 146 |
Naturally-occurring human serum antibodies to inner core lipopolysaccharide epitopes of Neisseria meningitidis protect against invasive meningococcal disease caused by isolates displaying homologous inner core structures
|
Jäkel, Anne
|
|
2008
|
26 |
Supplement 1 |
p. 6655-6663
9 p.
|
artikel
|
| 147 |
Neurovirulence evaluation of Venezuelan equine encephalitis (VEE) vaccine candidate V3526 in nonhuman primates
|
Fine, Donald L.
|
|
2008
|
26 |
Supplement 1 |
p. 3497-3506
10 p.
|
artikel
|
| 148 |
New malaria vaccine candidates based on the Plasmodium vivax Merozoite Surface Protein-1 and the TLR-5 agonist Salmonella Typhimurium FliC flagellin
|
Bargieri, Daniel Y.
|
|
2008
|
26 |
Supplement 1 |
p. 6132-6142
11 p.
|
artikel
|
| 149 |
Not just sheer luck! Immune correlates of protection against HIV-1 infection
|
Piacentini, Luca
|
|
2008
|
26 |
Supplement 1 |
p. 3002-3007
6 p.
|
artikel
|
| 150 |
Open-label, dose escalation phase I study in healthy volunteers to evaluate the safety and pharmacokinetics of a human monoclonal antibody to Clostridium difficile toxin A
|
Taylor, Claribel P.
|
|
2008
|
26 |
Supplement 1 |
p. 3404-3409
6 p.
|
artikel
|
| 151 |
Open-label trial of therapeutic immunization with oral V-5 Immunitor (V5) vaccine in patients with chronic hepatitis C
|
Batdelger, Dendev
|
|
2008
|
26 |
Supplement 1 |
p. 2733-2737
5 p.
|
artikel
|
| 152 |
Optimization of primary and secondary cervical cancer prevention strategies in an era of cervical cancer vaccination: A multi-regional health economic analysis
|
Rogoza, Raina M.
|
|
2008
|
26 |
Supplement 1 |
p. F46-F58
nvt p.
|
artikel
|
| 153 |
Optimization strategy for plasmid DNAs containing multiple-epitopes of foot-and-mouth disease virus by cis-expression with IL-2
|
Zhang, Hong-Ying
|
|
2008
|
26 |
Supplement 1 |
p. 769-777
9 p.
|
artikel
|
| 154 |
Overview of Human Papillomavirus-Based and Other Novel Options for Cervical Cancer Screening in Developed and Developing Countries
|
Cuzick, Jack
|
|
2008
|
26 |
Supplement 1 |
p. K29-K41
nvt p.
|
artikel
|
| 155 |
Oxidized and reduced mannan mediated MUC1 DNA immunization induce effective anti-tumor responses
|
Tang, Choon Kit
|
|
2008
|
26 |
Supplement 1 |
p. 3827-3834
8 p.
|
artikel
|
| 156 |
Parenteral administration of RF 8-2/6/7 rotavirus-like particles in a one-dose regimen induce protective immunity in mice
|
Istrate, Claudia
|
|
2008
|
26 |
Supplement 1 |
p. 4594-4601
8 p.
|
artikel
|
| 157 |
pcDNA-IL-12 vaccination blocks eosinophilic inflammation but not airway hyperresponsiveness following murine Toxocara canis infection
|
Malheiro, Adriana
|
|
2008
|
26 |
Supplement 1 |
p. 305-315
11 p.
|
artikel
|
| 158 |
Phase 2a trial of 0, 1, and 3 month and 0, 7, and 28 day immunization schedules of malaria vaccine RTS,S/AS02 in malaria-naïve adults at the Walter Reed Army Institute of Research
|
Kester, Kent E.
|
|
2008
|
26 |
Supplement 1 |
p. 2191-2202
12 p.
|
artikel
|
| 159 |
Phase 1 clinical trial of live attenuated Shigella dysenteriae type-1 ΔicsA Δent Δfep ΔstxA:HgR oral vaccine SC599 in healthy human adult volunteers
|
Sadorge, Christine
|
|
2008
|
26 |
Supplement 1 |
p. 978-987
10 p.
|
artikel
|
| 160 |
Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults
|
Nolan, Terry M.
|
|
2008
|
26 |
Supplement 1 |
p. 4160-4167
8 p.
|
artikel
|
| 161 |
Phase I study of a candidate vaccine based on recombinant HIV-1 gp160 (MN/LAI) administered by the mucosal route to HIV-seronegative volunteers: The ANRS VAC14 study
|
Pialoux, Gilles
|
|
2008
|
26 |
Supplement 1 |
p. 2657-2666
10 p.
|
artikel
|
| 162 |
Plasmid-based vaccination with candidate anthrax vaccine antigens induces durable type 1 and type 2 T-helper immune responses
|
Zhang, Yongxin
|
|
2008
|
26 |
Supplement 1 |
p. 614-622
9 p.
|
artikel
|
| 163 |
Pneumococcal seroepidemiology in Turkey: Implications for vaccine coverage
|
Erdem, Hakan
|
|
2008
|
26 |
Supplement 1 |
p. 1271-1273
3 p.
|
artikel
|
| 164 |
Post-apoptotic tumors are more palatable to dendritic cells and enhance their antigen cross-presentation activity
|
Brusa, Davide
|
|
2008
|
26 |
Supplement 1 |
p. 6422-6432
11 p.
|
artikel
|
| 165 |
Potential of Mw as a prophylactic vaccine against pulmonary tuberculosis
|
Katoch, K.
|
|
2008
|
26 |
Supplement 1 |
p. 1228-1234
7 p.
|
artikel
|
| 166 |
Potent specific immune responses induced by prime-boost-boost strategies based on DNA, adenovirus, and Sendai virus vectors expressing gag gene of Chinese HIV-1 subtype B
|
Yu, Shuangqing
|
|
2008
|
26 |
Supplement 1 |
p. 6124-6131
8 p.
|
artikel
|
| 167 |
Prevention of Coxiella burnetii shedding in infected dairy herds using a phase I C. burnetii inactivated vaccine
|
Guatteo, Raphaël
|
|
2008
|
26 |
Supplement 1 |
p. 4320-4328
9 p.
|
artikel
|
| 168 |
Production, quality control, stability and pharmacotoxicity of cGMP-produced Plasmodium falciparum AMA1 FVO strain ectodomain expressed in Pichia pastoris
|
Faber, Bart W.
|
|
2008
|
26 |
Supplement 1 |
p. 6143-6150
8 p.
|
artikel
|
| 169 |
Protection of guinea pigs and swine by a recombinant adenovirus expressing O serotype of foot-and-mouth disease virus whole capsid and 3C protease
|
Lu, Zengjun
|
|
2008
|
26 |
Supplement 1 |
p. G48-G53
nvt p.
|
artikel
|
| 170 |
Protective effect of a DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice
|
Qu, Daofeng
|
|
2008
|
26 |
Supplement 1 |
p. 4541-4548
8 p.
|
artikel
|
| 171 |
Quantitation of haemagglutinin in H5N1 influenza viruses reveals low haemagglutinin content of vaccine virus NIBRG-14 (H5N1)
|
Harvey, Ruth
|
|
2008
|
26 |
Supplement 1 |
p. 6550-6554
5 p.
|
artikel
|
| 172 |
Rabies awareness in eight Asian countries
|
Dodet, Betty
|
|
2008
|
26 |
Supplement 1 |
p. 6344-6348
5 p.
|
artikel
|
| 173 |
Rabies in Estonia: Situation before and after the first campaigns of oral vaccination of wildlife with SAG2 vaccine bait
|
Niin, Enel
|
|
2008
|
26 |
Supplement 1 |
p. 3556-3565
10 p.
|
artikel
|
| 174 |
Randomized, placebo-controlled, double-blind trial of the Na-ASP-2 Hookworm Vaccine in unexposed adults
|
Bethony, Jeffrey M.
|
|
2008
|
26 |
Supplement 1 |
p. 2408-2417
10 p.
|
artikel
|
| 175 |
Rational design of novel HIV-1 entry inhibitors by RANTES engineering
|
Vangelista, Luca
|
|
2008
|
26 |
Supplement 1 |
p. 3008-3015
8 p.
|
artikel
|
| 176 |
Reactogenicity of infant whole cell pertussis combination vaccine compared with acellular pertussis vaccines with or without simultaneous pneumococcal vaccine in the Netherlands
|
David, Silke
|
|
2008
|
26 |
Supplement 1 |
p. 5883-5887
5 p.
|
artikel
|
| 177 |
Recombinant DNA vaccine of the early secreted antigen ESAT-6 by Mycobacterium tuberculosis and Flt3 ligand enhanced the cell-mediated immunity in mice
|
Xu, Juan
|
|
2008
|
26 |
Supplement 1 |
p. 4519-4525
7 p.
|
artikel
|
| 178 |
Reduced dose pre-exposure primary and booster intradermal rabies vaccination with a purified chick embryo cell vaccine (PCECV) is immunogenic and safe in adults
|
Roukens, A.H.
|
|
2008
|
26 |
Supplement 1 |
p. 3438-3442
5 p.
|
artikel
|
| 179 |
Retracing our STEP towards a successful CTL-based HIV-1 vaccine
|
Yang, Otto O.
|
|
2008
|
26 |
Supplement 1 |
p. 3138-3141
4 p.
|
artikel
|
| 180 |
Safety and effectiveness against respiratory tract infections for pneumococcal conjugate vaccine co-administered with routine vaccine combinations
|
Adam, D.
|
|
2008
|
26 |
Supplement 1 |
p. 5944-5951
8 p.
|
artikel
|
| 181 |
Safety and efficacy of live attenuated influenza vaccine in children 2–7 years of age
|
Belshe, Robert B.
|
|
2008
|
26 |
Supplement 1 |
p. D10-D16
nvt p.
|
artikel
|
| 182 |
Safety and immunogenicity, after nasal application of HIV-1 DNA gagp37 plasmid vaccine in young mice
|
Hinkula, Jorma
|
|
2008
|
26 |
Supplement 1 |
p. 5101-5106
6 p.
|
artikel
|
| 183 |
Safety and immunogenicity of a DTaP-IPVVero (serum-free) combination vaccine in comparison to DTaP-IPVMkc when administered simultaneously with Haemophilus influenzae type b conjugate vaccine (PRP-T) in children at 2, 3.5, 5 and 16 months of age
|
Pietrzyk, Jacek J.
|
|
2008
|
26 |
Supplement 1 |
p. 5296-5303
8 p.
|
artikel
|
| 184 |
Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children
|
Nolan, Terry
|
|
2008
|
26 |
Supplement 1 |
p. 6383-6391
9 p.
|
artikel
|
| 185 |
Safety and immunogenicity of a 7-valent pneumococcal conjugate vaccine (Prevenar™): Primary dosing series in healthy Chinese infants
|
Li, Rong Cheng
|
|
2008
|
26 |
Supplement 1 |
p. 2260-2269
10 p.
|
artikel
|
| 186 |
Safety and immunogenicity of CRM197-conjugated pneumococcal–meningococcal C combination vaccine (9vPnC–MnCC) whether given in two or three primary doses
|
Sigurdardottir, Sigurveig Th.
|
|
2008
|
26 |
Supplement 1 |
p. 4178-4186
9 p.
|
artikel
|
| 187 |
Safety and immunogenicity of cytotoxic T-lymphocyte poly-epitope, DNA plasmid (EP HIV-1090) vaccine in healthy, human immunodeficiency virus type 1 (HIV-1)-uninfected adults
|
Gorse, Geoffrey J.
|
|
2008
|
26 |
Supplement 1 |
p. 215-223
9 p.
|
artikel
|
| 188 |
Safety and immunogenicity of recombinant low-dosage HIV-1 A vaccine candidates vectored by plasmid pTHr DNA or modified vaccinia virus Ankara (MVA) in humans in East Africa
|
Jaoko, Walter
|
|
2008
|
26 |
Supplement 1 |
p. 2788-2795
8 p.
|
artikel
|
| 189 |
Safety and immunogenicity of recombinant poxvirus HIV-1 vaccines in young adults on highly active antiretroviral therapy
|
Greenough, Thomas C.
|
|
2008
|
26 |
Supplement 1 |
p. 6883-6893
11 p.
|
artikel
|
| 190 |
Safety and immunogenicity of WRSd1, a live attenuated Shigella dysenteriae type 1 vaccine candidate
|
McKenzie, Robin
|
|
2008
|
26 |
Supplement 1 |
p. 3291-3296
6 p.
|
artikel
|
| 191 |
Safety and reactogenicity profile of an adjuvanted H5N1 pandemic candidate vaccine in adults within a phase III safety trial
|
Rümke, Hans C.
|
|
2008
|
26 |
Supplement 1 |
p. 2378-2388
11 p.
|
artikel
|
| 192 |
Safety of the RTS,S/AS02A malaria vaccine in Mozambican children during a Phase IIb trial
|
Sacarlal, Jahit
|
|
2008
|
26 |
Supplement 1 |
p. 174-184
11 p.
|
artikel
|
| 193 |
Scalable culture systems using different cell lines for the production of Peste des Petits ruminants vaccine
|
Silva, Ana Carina
|
|
2008
|
26 |
Supplement 1 |
p. 3305-3311
7 p.
|
artikel
|
| 194 |
Selection of serotype-specific vaccine candidate genes in Actinobacillus pleuropneumoniae and heterologous immunization with Propionibacterium acnes
|
Lei, Liancheng
|
|
2008
|
26 |
Supplement 1 |
p. 6274-6280
7 p.
|
artikel
|
| 195 |
Sendai virus recombinant vaccine expressing hPIV-3 HN or F elicits protective immunity and combines with a second recombinant to prevent hPIV-1, hPIV-3 and RSV infections
|
Zhan, Xiaoyan
|
|
2008
|
26 |
Supplement 1 |
p. 3480-3488
9 p.
|
artikel
|
| 196 |
Serotypes and pathogens in paediatric pneumonia
|
Hausdorff, William P.
|
|
2008
|
26 |
Supplement 1 |
p. B19-B23
nvt p.
|
artikel
|
| 197 |
Sexual dimorphism of humoral immunity with human vaccines
|
Cook, Ian Francis
|
|
2008
|
26 |
Supplement 1 |
p. 3551-3555
5 p.
|
artikel
|
| 198 |
Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5–49 years of age
|
Block, Stan L.
|
|
2008
|
26 |
Supplement 1 |
p. 4940-4946
7 p.
|
artikel
|
| 199 |
SOCS1 downregulation in dendritic cells promotes memory T-cell responses
|
Aldrich, Melissa
|
|
2008
|
26 |
Supplement 1 |
p. 1128-1135
8 p.
|
artikel
|
| 200 |
Strategies for financial sustainability of immunization programs: A review of the strategies from 50 national immunization program financial sustainability plans
|
Kamara, Lidija
|
|
2008
|
26 |
Supplement 1 |
p. 6717-6726
10 p.
|
artikel
|
| 201 |
Strategies for induction of protective immunity to bovine herpesvirus-1 in newborn calves with maternal antibodies
|
van Drunen Littel-van den Hurk, S.
|
|
2008
|
26 |
Supplement 1 |
p. 3103-3111
9 p.
|
artikel
|
| 202 |
Structured treatment interruptions (STIs) in HIV-1 infected pediatric populations increases interferon gamma production and reduces viremia
|
Borkowsky, William
|
|
2008
|
26 |
Supplement 1 |
p. 3086-3089
4 p.
|
artikel
|
| 203 |
Synthetic peptide AT20 coupled to KLH elicits antibodies against a conserved conformational epitope from a major functional area of the HIV-1 matrix protein p17
|
Fiorentini, Simona
|
|
2008
|
26 |
Supplement 1 |
p. 4758-4765
8 p.
|
artikel
|
| 204 |
TBE infection in an incomplete immunized person at-risk who lives in a high-endemic area—Impact on current recommendations for immunization of high-risk groups
|
Plíšek, Stanislav
|
|
2008
|
26 |
Supplement 1 |
p. 301-304
4 p.
|
artikel
|
| 205 |
The antifertility effects of DNA vaccine-induced immune responses against uroguanylin
|
Sun, Jing
|
|
2008
|
26 |
Supplement 1 |
p. 3696-3704
9 p.
|
artikel
|
| 206 |
The contribution of type I interferon signaling to immunity induced by alphavirus replicon vaccines
|
Thompson, Joseph M.
|
|
2008
|
26 |
Supplement 1 |
p. 4998-5003
6 p.
|
artikel
|
| 207 |
The effect of oral administration of a homologous hilA mutant strain on the long-term colonization and transmission of Salmonella Enteritidis in broiler chickens
|
Bohez, Lotte
|
|
2008
|
26 |
Supplement 1 |
p. 372-378
7 p.
|
artikel
|
| 208 |
The emerging role of innate immunity in protection against HIV-1 infection
|
Lehner, T.
|
|
2008
|
26 |
Supplement 1 |
p. 2997-3001
5 p.
|
artikel
|
| 209 |
The epidemiology of mumps in Italy
|
Gabutti, G.
|
|
2008
|
26 |
Supplement 1 |
p. 2906-2911
6 p.
|
artikel
|
| 210 |
The LTK63 adjuvant improves protection conferred by Ag85B DNA-protein prime-boosting vaccination against Mycobacterium tuberculosis infection by dampening IFN-γ response
|
Palma, Carla
|
|
2008
|
26 |
Supplement 1 |
p. 4237-4243
7 p.
|
artikel
|
| 211 |
The novel adjuvant IC31® strongly improves influenza vaccine-specific cellular and humoral immune responses in young adult and aged mice
|
Riedl, Karin
|
|
2008
|
26 |
Supplement 1 |
p. 3461-3468
8 p.
|
artikel
|
| 212 |
The presence of a deletion sequence in the BHV-1 UL49 homolog in a live attenuated vaccine for infectious bovine rhinotracheitis (IBR)
|
Kamiyoshi, Takeshi
|
|
2008
|
26 |
Supplement 1 |
p. 477-485
9 p.
|
artikel
|
| 213 |
The relative immunogenicity of DNA vaccines delivered by the intramuscular needle injection, electroporation and gene gun methods
|
Wang, Shixia
|
|
2008
|
26 |
Supplement 1 |
p. 2100-2110
11 p.
|
artikel
|
| 214 |
The risk of simple febrile seizures after immunisation with a new group B meningococcal vaccine, New Zealand
|
Stehr-Green, Paul
|
|
2008
|
26 |
Supplement 1 |
p. 739-742
4 p.
|
artikel
|
| 215 |
The safety and tolerability of an HIV-1 DNA prime–protein boost vaccine (DP6-001) in healthy adult volunteers
|
Kennedy, Jeffrey S.
|
|
2008
|
26 |
Supplement 1 |
p. 4420-4424
5 p.
|
artikel
|
| 216 |
The safety of post-exposure vaccination of mice infected with Mycobacterium tuberculosis
|
Derrick, Steven C.
|
|
2008
|
26 |
Supplement 1 |
p. 6092-6098
7 p.
|
artikel
|
| 217 |
The Tat protein broadens T cell responses directed to the HIV-1 antigens Gag and Env: Implications for the design of new vaccination strategies against AIDS
|
Gavioli, Riccardo
|
|
2008
|
26 |
Supplement 1 |
p. 727-737
11 p.
|
artikel
|
| 218 |
Th1-stimulatory polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1kDa offers long-lasting protection against experimental visceral leishmaniasis
|
Kumari, Shraddha
|
|
2008
|
26 |
Supplement 1 |
p. 5700-5711
12 p.
|
artikel
|
| 219 |
TLR ligands that stimulate the metabolism of vitamin D3 in activated murine dendritic cells can function as effective mucosal adjuvants to subcutaneously administered vaccines
|
Enioutina, Elena Y.
|
|
2008
|
26 |
Supplement 1 |
p. 601-613
13 p.
|
artikel
|
| 220 |
Toxoplasma gondii protease inhibitor-1 (TgPI-1) is a novel vaccine candidate against toxoplasmosis
|
Cuppari, Anahi Fernandez
|
|
2008
|
26 |
Supplement 1 |
p. 5040-5045
6 p.
|
artikel
|
| 221 |
Twenty-two years follow-up of a prospective randomized trial of hepatitis B vaccines without booster dose in children: Final report
|
But, David Yiu-Kuen
|
|
2008
|
26 |
Supplement 1 |
p. 6587-6591
5 p.
|
artikel
|
| 222 |
Two versus three doses of a meningococcal C conjugate vaccine concomitantly administered with a hexavalent DTaP-IPV-HBV/Hib vaccine in healthy infants
|
Schmitt, Heinz-J.
|
|
2008
|
26 |
Supplement 1 |
p. 2242-2252
11 p.
|
artikel
|
| 223 |
US military service members vaccinated against smallpox in 2003 and 2004 experience a slightly higher risk of hospitalization postvaccination
|
Jacobson, Isabel G.
|
|
2008
|
26 |
Supplement 1 |
p. 4048-4056
9 p.
|
artikel
|
| 224 |
Vaccination of cattle against B. bovis infection with live attenuated parasites and non-viable immunogens
|
Fish, Lea
|
|
2008
|
26 |
Supplement 1 |
p. G29-G33
nvt p.
|
artikel
|
| 225 |
Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers
|
Vandepapelière, Pierre
|
|
2008
|
26 |
Supplement 1 |
p. 1375-1386
12 p.
|
artikel
|
| 226 |
Vaccine against infectious bovine keratoconjunctivitis: A new approach to optimize the production of highly piliated Moraxella bovis cells
|
Prieto, Claudia I.
|
|
2008
|
26 |
Supplement 1 |
p. 6542-6549
8 p.
|
artikel
|
| 227 |
V3 CTL epitope density in a single recombinant molecule antigen differentially affects the number and activity of primary and memory CD8+ T cells
|
Lu, Lu
|
|
2008
|
26 |
Supplement 1 |
p. 845-852
8 p.
|
artikel
|
| 228 |
Viral, HLA and T cell elements in cross-reactive immune responses to HIV-1 subtype A, CRF01_AE and CRF02_AG vaccine sequence in Ivorian blood donors
|
Aidoo, M.
|
|
2008
|
26 |
Supplement 1 |
p. 4830-4839
10 p.
|
artikel
|
| 229 |
Vitamin A supplements are well tolerated with the pentavalent vaccine
|
Newton, Sam
|
|
2008
|
26 |
Supplement 1 |
p. 6608-6613
6 p.
|
artikel
|
Tijdschrift beschrijving